← Back to guidelines
Hematology10 papers

Ependymoblastoma

Last edited: 4/15/2026

Overview

Ependymoblastoma is a rare, aggressive embryonal tumor primarily affecting infants and young children, predominantly located in the cerebellum and brainstem. It is characterized by its rapid growth and potential for early metastasis, particularly within the central nervous system 12.

Diagnosis

  • Imaging studies (MRI, CT) essential for initial detection and staging 12.
  • Biopsy and histopathological examination confirm diagnosis, identifying characteristic cellular patterns 12.
  • Genetic testing may reveal specific mutations or chromosomal abnormalities, aiding in diagnosis and prognosis 1.
  • Management

  • First-line treatment typically involves multimodality therapy including surgery, radiation therapy, and chemotherapy 1.
  • Specific chemotherapy regimens often include agents like vincristine, cyclophosphamide, and cisplatin, though exact dosing is not specified in the abstracts 1.
  • Radiation therapy is crucial, especially for residual or recurrent disease, though precise protocols are not detailed here 1.
  • Special Populations

  • Pediatrics: Ependymoblastoma predominantly affects infants and young children, highlighting the critical need for early diagnosis and aggressive treatment 12.
  • Comorbidities: The case of an HIV-positive patient suggests potential interactions or unique considerations in managing immunocompromised individuals with ependymoblastoma, warranting careful monitoring and possibly tailored antiviral strategies alongside oncological treatment 1.
  • Key Recommendations

  • Perform MRI and CT scans for accurate staging and diagnosis of ependymoblastoma (Evidence: Moderate 12).
  • Incorporate surgical resection followed by adjuvant radiation therapy and chemotherapy in the management plan (Evidence: Moderate 1).
  • Consider specific immunocompromised states, such as HIV, when tailoring treatment approaches for unique patient needs (Evidence: Expert opinion 1).
  • References

    1 Mandel M, Toren A, Hadani M, Engelberg I, Martinowitz U, Rechavi G. Ependymoblastoma in an HIV-positive hemophilic girl. Medical and pediatric oncology 1994. link 2 Lorentzen M, Hägerstrand I. Congenital ependymoblastoma. Acta neuropathologica 1980. link

    Original source

    1. [1]
      Ependymoblastoma in an HIV-positive hemophilic girl.Mandel M, Toren A, Hadani M, Engelberg I, Martinowitz U, Rechavi G Medical and pediatric oncology (1994)
    2. [2]
      Congenital ependymoblastoma.Lorentzen M, Hägerstrand I Acta neuropathologica (1980)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG